Lactobacillus Plantarum IS 10560 Supplementation in Women With Functional Constipation

• Status: Completed
• Trial end date: 2018-08-22
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the investigators measured the SCFA (Butyrate, Acetate and Propionate) as a Biomarker improvement symptom and quality of life women with functional constipation after supplementation of commensal bacterial fermented milk Lactobacillus plantarum (isolated from indigenous probiotics from Dadih, West Sumatra) for 21 days

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fakultas Kedokteran Universitas Indonesia
• Collaborator: United States Agency for International Development (USAID)

Criteria

Inclusion Criteria:

• Being declared healthy based on initial examination and the Structured Interview Questionnaire (SIQ)

• Having the symptoms and signs of functional constipation refer to ROME IV

• Able to communicate well

• Able to consume 1 bottle of fermented milk each day for three weeks

• Not using antibiotic no later than one week before supplementation

Exclusion Criteria:

• Diagnosed with functional bowel disorder

• Using anesthesia at least 4 weeks before treatment

• Having a serious pathological disorder (carcinoma)

• During healing phase of acute gastrointestinal disorders at least 4 weeks before treatment

• Having severe heart disease

• Taking chronic medications such as antidepressants or analgesics